Glenmark Pharmaceuticals Ltd - Company Profile
Powered by 
All the sales intelligence you need on Glenmark Pharmaceuticals Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Glenmark Pharmaceuticals Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Glenmark Pharmaceuticals Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Glenmark Pharmaceuticals Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20230391737A1 | Application | Process for preparation of tafamidis and salts thereof | C07B2200/13; C07D263/57 | December 07, 2023 |
| EP4077278A4 | Search Report | Verfahren zur herstellung von brivaracetam | C07B2200/07; C07C237/06; C07C2601/14; C07D207/27 | December 06, 2023 |
| WO2023223253A1 | Application | Process for preparation of ruxolitinib | November 23, 2023 | |
| WO2023223188A1 | Application | Process for the preparation of finerenone and intermediates thereof | November 23, 2023 | |
| WO2023213998A1 | Application | Cd3/bcma/cd38 trispecific antibodies | A61K2039/505; A61P33/00; C07K16/2809; C07K16/2878; C07K16/2896; C07K2317/21; C07K2317/31; C07K2317/33; C07K2317/34; C07K2317/35; C07K2317/515; C07K2317/524; C07K2317/55; C07K2317/565; C07K2317/622; C07K2317/64; C07K2317/70; C07K2317/71; C07K2317/72; C07K2317/73; C07K2317/74; C07K2317/75; C07K2317/76; C07K2317/92; C07K2317/94 | November 09, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer